ZNF226
gene geneOn this page
Summary
ZNF226 (zinc finger protein 226, HGNC:13019) is a protein-coding gene on chromosome 19q13.31, encoding Zinc finger protein 226 (Q9NYT6). May be involved in transcriptional regulation.
Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7769 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 149 total
- MANE Select transcript:
NM_001032373
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13019 |
| Approved symbol | ZNF226 |
| Name | zinc finger protein 226 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000167380 |
| Ensembl biotype | protein_coding |
| Entrez | 7769 |
Gene structure
Transcript identifiers
Ensembl transcripts: 32 — 31 protein_coding, 1 retained_intron
ENST00000300823, ENST00000337433, ENST00000413984, ENST00000454662, ENST00000585560, ENST00000585678, ENST00000586203, ENST00000586286, ENST00000586914, ENST00000588127, ENST00000588742, ENST00000588795, ENST00000588883, ENST00000589160, ENST00000590089, ENST00000590467, ENST00000590524, ENST00000590578, ENST00000590759, ENST00000852800, ENST00000852801, ENST00000852802, ENST00000929407, ENST00000929408, ENST00000929409, ENST00000929410, ENST00000929411, ENST00000929412, ENST00000929413, ENST00000966188, ENST00000966189, ENST00000966190
RefSeq mRNA: 20 — MANE Select: NM_001032373
NM_001032372, NM_001032373, NM_001032374, NM_001146220, NM_001319088, NM_001319089, NM_001319090, NM_001388168, NM_001388169, NM_001388170, NM_001388171, NM_001388172, NM_001388173, NM_001388174, NM_001388175, NM_001388176, NM_001388177, NM_001388178, NM_015919, NM_016444
CCDS: CCDS46102, CCDS46103
Canonical transcript exons
ENST00000337433 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001112490 | 44172860 | 44172952 |
| ENSE00001666581 | 44165100 | 44165142 |
| ENSE00001730672 | 44165757 | 44165807 |
| ENSE00002453821 | 44172088 | 44172214 |
| ENSE00003574428 | 44170035 | 44170095 |
| ENSE00003918232 | 44175498 | 44177685 |
Expression profiles
Bgee: expression breadth ubiquitous, 272 present calls, max score 93.60.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.9066 / max 200.9506, expressed in 1766 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176252 | 11.0922 | 1758 |
| 176253 | 0.8144 | 520 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 93.60 | gold quality |
| endothelial cell | CL:0000115 | 93.42 | gold quality |
| calcaneal tendon | UBERON:0003701 | 92.97 | gold quality |
| adrenal tissue | UBERON:0018303 | 92.66 | gold quality |
| right adrenal gland | UBERON:0001233 | 92.44 | gold quality |
| tendon | UBERON:0000043 | 92.41 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 92.41 | gold quality |
| left adrenal gland | UBERON:0001234 | 91.65 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 91.39 | gold quality |
| adrenal gland | UBERON:0002369 | 91.02 | gold quality |
| adrenal cortex | UBERON:0001235 | 90.89 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.72 | gold quality |
| pituitary gland | UBERON:0000007 | 90.65 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.76 | gold quality |
| apex of heart | UBERON:0002098 | 88.66 | gold quality |
| corpus callosum | UBERON:0002336 | 88.51 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.41 | gold quality |
| right uterine tube | UBERON:0001302 | 88.35 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 88.16 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 87.85 | gold quality |
| medial globus pallidus | UBERON:0002477 | 87.75 | gold quality |
| amniotic fluid | UBERON:0000173 | 87.66 | gold quality |
| gall bladder | UBERON:0002110 | 87.64 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.41 | gold quality |
| mucosa of stomach | UBERON:0001199 | 87.25 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 87.19 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.10 | gold quality |
| cingulate cortex | UBERON:0003027 | 86.97 | gold quality |
| stromal cell of endometrium | CL:0002255 | 86.91 | gold quality |
| substantia nigra | UBERON:0002038 | 86.79 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-124858 | no | 216.06 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2548.1 | ZNF226 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
Upstream regulators (CollecTRI, top): BRD1, RBAK, STAT1
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp61 | ENSMUSG00000050605 |
| rattus_norvegicus | Zfp94 | ENSRNOG00000019416 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 226 — Q9NYT6 (reviewed: Q9NYT6)
All UniProt accessions (11): Q9NYT6, K7EJ66, K7EK05, K7EKQ6, K7EL77, K7ELA3, K7ELM4, K7EPU4, K7EQC3, K7ERY1, K7ESM6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NYT6-1 | 1 | yes |
| Q9NYT6-2 | 2 |
RefSeq proteins (20): NP_001027544, NP_001027545, NP_001027546, NP_001139692, NP_001306017, NP_001306018, NP_001306019, NP_001375097, NP_001375098, NP_001375099, NP_001375100, NP_001375101, NP_001375102, NP_001375103, NP_001375104, NP_001375105, NP_001375106, NP_001375107, NP_057003, NP_057528 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (26 total): zinc finger region 19, splice variant 2, chain 1, domain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NYT6-F1 | 65.30 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 68 (showing top):
GOZGIT_ESR1_TARGETS_DN, PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP, KOYAMA_SEMA3B_TARGETS_UP, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, BASAKI_YBX1_TARGETS_DN, HAN_SATB1_TARGETS_DN, GEORGES_TARGETS_OF_MIR192_AND_MIR215, ONDER_CDH1_TARGETS_1_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, KRIEG_KDM3A_TARGETS_NOT_HYPOXIA
GO Biological Process (3): negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (4): zinc ion binding (GO:0008270), sequence-specific DNA binding (GO:0043565), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transition metal ion binding | 1 |
| DNA binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
502 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF226 | CCDC51 | Q96ER9 | 480 |
| ZNF226 | TMA7 | Q9Y2S6 | 418 |
| ZNF226 | ANKEF1 | Q9NU02 | 379 |
| ZNF226 | SHISAL1 | Q3SXP7 | 371 |
| ZNF226 | LRRC46 | Q96FV0 | 370 |
| ZNF226 | TSPYL4 | Q9UJ04 | 348 |
| ZNF226 | CCDC57 | Q2TAC2 | 325 |
| ZNF226 | IGFLR1 | Q9H665 | 318 |
| ZNF226 | CHAC2 | Q8WUX2 | 314 |
| ZNF226 | GXYLT1 | Q4G148 | 313 |
| ZNF226 | DNASE1L1 | P49184 | 309 |
| ZNF226 | EML2 | O95834 | 308 |
| ZNF226 | DNAJC9 | Q8WXX5 | 300 |
| ZNF226 | SMPDL3A | Q92484 | 298 |
| ZNF226 | OTOP1 | Q7RTM1 | 274 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF226 | MRPL58 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF226 | SSBP3 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ATF4 | ZNF226 | psi-mi:“MI:0915”(physical association) | 0.370 |
| H2BC10 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (14): ZNF226 (Proximity Label-MS), ZNF226 (Affinity Capture-MS), ZNF226 (Proximity Label-MS), ZNF226 (Proximity Label-MS), ZNF226 (Proximity Label-MS), ZNF226 (Affinity Capture-MS), ZNF226 (Affinity Capture-MS), ZNF226 (Proximity Label-MS), ZNF226 (Proximity Label-MS), ZNF226 (Proximity Label-MS), ZNF226 (Affinity Capture-MS), ZNF226 (Affinity Capture-RNA), ZNF226 (Two-hybrid), SSBP3 (Two-hybrid)
ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
149 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 130 |
| Likely benign | 9 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1026 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:44165808:G:GG | donor_gain | 1.0000 |
| 19:44165810:GA:G | donor_gain | 1.0000 |
| 19:44165812:G:GG | donor_gain | 1.0000 |
| 19:44170033:A:AG | acceptor_gain | 1.0000 |
| 19:44170034:G:GA | acceptor_gain | 1.0000 |
| 19:44170034:GTTC:G | acceptor_gain | 1.0000 |
| 19:44170034:GTTCA:G | acceptor_gain | 1.0000 |
| 19:44170092:CAAGG:C | donor_loss | 1.0000 |
| 19:44170094:AGGT:A | donor_loss | 1.0000 |
| 19:44170097:T:G | donor_loss | 1.0000 |
| 19:44172080:T:TA | acceptor_gain | 1.0000 |
| 19:44172083:C:A | acceptor_gain | 1.0000 |
| 19:44172085:TAGGA:T | acceptor_loss | 1.0000 |
| 19:44172086:A:AG | acceptor_gain | 1.0000 |
| 19:44172086:A:C | acceptor_loss | 1.0000 |
| 19:44172086:AG:A | acceptor_gain | 1.0000 |
| 19:44172087:G:GT | acceptor_gain | 1.0000 |
| 19:44172087:GG:G | acceptor_gain | 1.0000 |
| 19:44172087:GGA:G | acceptor_gain | 1.0000 |
| 19:44172087:GGAA:G | acceptor_gain | 1.0000 |
| 19:44172162:G:GT | donor_gain | 1.0000 |
| 19:44172181:ATG:A | donor_gain | 1.0000 |
| 19:44172211:G:GG | donor_gain | 1.0000 |
| 19:44172211:GTGG:G | donor_loss | 1.0000 |
| 19:44172213:GG:G | donor_gain | 1.0000 |
| 19:44172214:GG:G | donor_gain | 1.0000 |
| 19:44172214:GGTG:G | donor_loss | 1.0000 |
| 19:44172215:G:GG | donor_gain | 1.0000 |
| 19:44172215:GTGAG:G | donor_loss | 1.0000 |
| 19:44172220:G:GT | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000012879 (19:44166959 C>A,T), RS1000031956 (19:44175686 AT>A), RS1000082345 (19:44175467 C>CAAAAAAAAAA), RS1000113218 (19:44163870 A>G), RS1000198165 (19:44167068 A>G), RS1000321460 (19:44169479 C>T), RS1000329226 (19:44197975 A>T), RS1000395961 (19:44164104 C>T), RS1000491472 (19:44188610 G>A), RS1000630455 (19:44188994 C>T), RS1000632035 (19:44198390 C>G), RS1000708757 (19:44184089 G>A), RS1000710744 (19:44176926 T>C,G), RS1000790116 (19:44182355 A>G), RS1000791731 (19:44191713 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, affects cotreatment | 6 |
| Formaldehyde | decreases expression, increases expression | 3 |
| trichostatin A | decreases expression, affects cotreatment | 2 |
| sodium arsenite | decreases expression, increases expression | 2 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Estradiol | affects expression, decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| methylparaben | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaldehyde | decreases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Coumestrol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.